Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation

Guereno, M; Pastore, MD; Lugones, AC; Cercato, M; Todaro, L; Urtreger, A; Peters, MG

Peters, MG (corresponding author), Univ Buenos Aires, Inst Oncol AH Roffo, CONICET, Area Invest, Av San Martin 5481,C1417DTB, Buenos Aires, DF, Argentina.

EUROPEAN JOURNAL OF CELL BIOLOGY, 2020; 99 (6):

Abstract

GPC3 is a proteoglycan involved in the control of proliferation and survival, which has been linked to several tumor types. In this respect, we previo......

Full Text Link